Home1734 • TPE
add
Sinphar Pharmaceutical Co Ltd
Previous close
$31.05
Day range
$30.75 - $31.10
Year range
$28.60 - $36.30
Market cap
5.62B TWD
Avg Volume
152.16K
P/E ratio
18.49
Dividend yield
-
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
(TWD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 854.39M | 14.14% |
Operating expense | 260.80M | 52.23% |
Net income | 81.77M | -25.57% |
Net profit margin | 9.57 | -34.76% |
Earnings per share | 0.45 | — |
EBITDA | 163.28M | -7.03% |
Effective tax rate | 23.61% | — |
Balance Sheet
Total assets
Total liabilities
(TWD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.18B | 8.96% |
Total assets | 6.30B | 0.75% |
Total liabilities | 2.75B | -3.54% |
Total equity | 3.55B | — |
Shares outstanding | 182.07M | — |
Price to book | 1.73 | — |
Return on assets | 3.46% | — |
Return on capital | 4.05% | — |
Cash Flow
Net change in cash
(TWD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | 81.77M | -25.57% |
Cash from operations | 188.17M | 33.64% |
Cash from investing | -90.12M | -6.60% |
Cash from financing | -80.53M | -381.35% |
Net change in cash | 13.74M | -82.69% |
Free cash flow | -69.82M | -504.36% |
About
Founded
1977
Headquarters
Website
Employees
984